Literature DB >> 15468055

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.

Qizhi Tang1, Elisa K Boden, Kammi J Henriksen, Helene Bour-Jordan, Mingying Bi, Jeffrey A Bluestone.   

Abstract

Both CTLA-4 and TGF-beta have been implicated in suppression by CD4+CD25+ regulatory T cells (Treg). In this study, the relationship between CTLA-4 and TGF-beta in Treg function was examined. Blocking CTLA-4 on wild-type Treg abrogated their suppressive activity in vitro, whereas neutralizing TGF-beta had no effect, supporting a TGF-beta-independent role for CTLA-4 in Treg-mediated suppression in vitro. In CTLA-4-deficient mice, Treg development and homeostasis was normal. Moreover, Treg from CTLA-4-deficient mice exhibited uncompromised suppressive activity in vitro. These CTLA-4-deficient Treg expressed increased levels of the suppressive cytokines IL-10 and TGF-beta, and in vitro suppression mediated by CTLA-4(-/-) Treg was markedly reduced by neutralizing TGF-beta, suggesting that CTLA-4-deficient Treg develop a compensatory suppressive mechanism through CTLA-4-independent production of TGF-beta. Together, these data suggest that CTLA-4 regulates Treg function by two distinct mechanisms, one during functional development of Treg and the other during the effector phase, when the CTLA-4 signaling pathway is required for suppression. These results help explain contradictions in the literature and support the existence of functionally distinct Treg.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15468055     DOI: 10.1002/eji.200425143

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  134 in total

1.  Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.

Authors:  Sebastian Zeissig; Britt-Sabina Petersen; Michal Tomczak; Espen Melum; Emilie Huc-Claustre; Stephanie K Dougan; Jon K Laerdahl; Björn Stade; Michael Forster; Stefan Schreiber; Dascha Weir; Alan M Leichtner; Andre Franke; Richard S Blumberg
Journal:  Gut       Date:  2014-11-03       Impact factor: 23.059

2.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

Review 3.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

4.  Identification of a unique double-negative regulatory T-cell population.

Authors:  Byung O Lee; Joyce E Jones; Cory J Peters; David Whitacre; Lars Frelin; Janice Hughes; Won-Keun Kim; David R Milich
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

5.  CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood.

Authors:  Ning Yu; Xiaomei Li; Weiya Song; Dongmei Li; Daliang Yu; Xiaofeng Zeng; Mengtao Li; Xiaomei Leng; Xiangpei Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

6.  Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

Authors:  Alejo Chorny; Elena Gonzalez-Rey; Amelia Fernandez-Martin; David Pozo; Doina Ganea; Mario Delgado
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

7.  Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function.

Authors:  Dat Q Tran; Deborah D Glass; Gulbu Uzel; Dirk A Darnell; Christine Spalding; Steven M Holland; Ethan M Shevach
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIV(mac251) infection.

Authors:  M Vaccari; A Boasso; Z-M Ma; V Cecchinato; D Venzon; M N Doster; W P Tsai; G M Shearer; D Fuchs; B K Felber; G N Pavlakis; C J Miller; G Franchini
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

Review 9.  Restoring Regulatory T Cells in Type 1 Diabetes.

Authors:  Allyson Spence; Qizhi Tang
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

10.  Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.

Authors:  Nitya Jain; Hai Nguyen; Cynthia Chambers; Joonsoo Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.